David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to The post Investment...
Scientists at Rice University created a rapid COVID-19 test that is based on the gene editing CRISPR-Cas system. The researchers modified the Cas-13 protein...
The pharmaceutical giant, still riding high on the sales of Comirnaty and Paxlovid, is looking to a future of innovative oncology drugs and vaccines based...
Amgen is equipped with a broad and diverse product portfolio, commercial capabilities, and levers for delivering mid-single digit revenue growth over this...
2022 has been marked by the first year of leadership under CEO Joaquin Duato and the anticipated separation of the company’s consumer health busines...
Targeted business development acquisitions, improvements in R&D and operating performance, and a strengthened post-demerger balance sheet are creating...
It might seem like luck for a company to trip over a multi-billion dollar COVID treatment already lurking in its pipeline – but perhaps not so...
A strong product pipeline and increased group sales confirm that Roche is on the right growth path.
Merck’s exceptional revenue growth in 2021 and the first half of 2022 came thanks to three big brands, one of which is not even approved by...
With recent years of acquisitions and divestitures in the rearview, Takeda can focus on what matters most: growing its brands.
In this final webinar of a four-part series on RNA, cohosted by GEN and The CRISPR Journal, we will delve into the delivery question surrounding mRNA...
For the very first time, a study led by Julian Chen and his group in Arizona State University’s School of Molecular Sciences and the Biodesign Institute’s...
CHICAGO — While its competitor is on the cusp of likely securing the first FDA nod, Iveric Bio is trudging ahead with its potential treatment for geographic...
Nenad Grmusa Nenad Grmusa was “really happy” at Takeda, where he’d been for more than a decade in various R&D strategy and finance positions....
UCLA scientists report positive preclinical results on the safety and efficacy of an RNA vaccine (ZVAX) against the mosquito borne Zika virus that severely...
Wastewater-based epidemiology (WBE) has been shown to be an excellent means of understanding the spread of SARS-CoV-2 in communities. It is now used in...
Scientists at Shanghai Tongji University in China have created a face mask that can alert the wearer to the presence of respiratory viruses in the surrounding...
NEWS RELEASE Credit: Jeff Fitlow/Rice University NEWS RELEASE Avery Franklin 713-348-6327 averyrf@rice.edu Jade Boyd 713-348-6778 jadeboyd@rice.edu HOUSTON...
Right around the beginning of the year, we got a close-up look at what happens after a boom ripples through biotech. The crash of life sciences...
How do the hundreds of individual pieces that make up viruses assemble into shapes capable of spreading disease from cell to cell? Credit: Brome mosaic...
Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s The post Reconfiguring...
Canadian scientists have made significant contributions during the pandemic response, including vital roles in developing COVID-19 vaccines. But underfunding...
This guidance replaces previous conditional recommendations for the use of these drugs and is based on emerging evidence that they’re not likely to work...
BUFFALO, NY- September 15, 2022 – A new research paper was published on the cover of Aging (listed as “Aging (Albany NY)” by Medline/PubMed and...
September 15, 2022, CLEVELAND: Researchers from Cleveland Clinic’s Florida Research and Innovation Center (FRIC) found that disruption of a cellular...
By Joshua Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC By all accounts, 2022 did not start according to...
Earlier this year, Jonathan Epstein and other scientists at Penn published a paper in Science that spelled out the intriguing results of a mouse study....
Even low doses of alcohol prime the brain for addiction by triggering changes in the epigenome and transcriptome, a new study on rodents shows. Using ATAC-seq,...
Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19,...
Giuseppe Ciaramella joined Moderna in 2014, back when the mRNA specialist only employed about 70 people. There, as CSO of the infectious disease division,...